169280-82-4

Basic information

• Product Name: 3-Pyridinecarboxylic acid, 6-[[(1,1-diMethylethoxy)carbonyl]aMino]-, ethyl ester
• Synonyms: 3-Pyridinecarboxylic acid, 6-[[(1,1-diMethylethoxy)carbonyl]aMino]-, ethyl ester;Ethyl 6-{[(tert-butoxy)carbonyl]amino}pyridine-3-carboxylate;6-tert-Butoxycarbonylamino-nicotinic acid ethyl ester
• CAS NO: 169280-82-4
• Molecular Formula: C₁₃H₁₈N₂O₄
• Molecular Weight: 266.29302
• Mol File: 169280-82-4.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 336.7±27.0 °C(Predicted)
• Appearance: /
• Density: 1.177±0.06 g/cm3(Predicted)
• PKA: 12.02±0.70(Predicted)
• CAS DataBase Reference: 3-Pyridinecarboxylic acid, 6-[[(1,1-diMethylethoxy)carbonyl]aMino]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarboxylic acid, 6-[[(1,1-diMethylethoxy)carbonyl]aMino]-, ethyl ester(169280-82-4)
• EPA Substance Registry System: 3-Pyridinecarboxylic acid, 6-[[(1,1-diMethylethoxy)carbonyl]aMino]-, ethyl ester(169280-82-4)

Safety Data

• Hazardous Substances Data: 169280-82-4(Hazardous Substances Data)

Upstream product

• 39658-41-8 ethyl-6-amino-nicotinate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 463-77-4 carbamic Acid 
• 3167-49-5 6-aminonicotinic acid 

Downstream Products

• 169280-83-5 (5-hydroxymethylpyridin-2-yl)-carbamic acid t-butyl ester 
• 1197331-07-9 8-(3,5-dimethoxy-phenyl)-quinoxaline-5-carboxylic acid [5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-amide 
• 231958-14-8 6-[(tert-butoxycarbonyl)amino]nicotinic acid 
• 1588422-80-3 3-(2,6-difluorophenyl)-1-ethyl-7-((5-((4-methylpiperazin-1-yl)methyl)pyridin-2-yl)amino)-1,6-naphthyridin-2(1H)-one 
• 1585145-71-6 7-(2-chloro-6-fluoro-3,5-dimethoxyphenyl)-N-[5-(4-methylpiperazin-1-ylmethyl)pyridin-2-yl]isoquinolin-3-amine 
• 1585145-64-7 7-(2,6-difluoro-3,5-dimethoxyphenyl)-N-{5-[(4-methylpiperazin-1-yl)methyl]pyridin-2-yl}isoquinolin-3-amine 
• 1197333-44-0 5-(4-methyl-piperazin-1-ylmethyl)-pyridin-2-ylamine 
• 1585145-51-2 7-(2,6-dichloro-3,5-dimethoxyphenyl)-N-{5-[(4-methylpiperazin-1-yl)methyl]pyridin-2-yl}isoquinolin-3-amine 

Relevant articles and documents

Protein kinase inhibitor and its preparation method and medical application

The invention provides a compound shown in the structural formula I or its tautomer, mesomer, racemate, enantiomer, diastereoisomer or their mixture, or a pharmaceutically acceptable salt or solvate of the compound shown in the structural formula I or its tautomer, mesomer, racemate, enantiomer, diastereoisomer or their mixture. The ring A, R1, R2, R3 and R4 are defined in the specification. The invention also provides a preparation method of the compound shown in the structural formula I and a use of the compound in preparation of a drug for treating cell proliferative disorder.

3-(ARYL- OR HETEROARYL-AMINO)-7-(3,5-DIMETHOXYPHENYL)ISOQUINOLINE DERIVATIVES AS FGFR INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS OR DYSPLASIA

The invention relates to compounds of formula (I) wherein R1, R2, R2a, R3 have the meaning as cited in the description and the claims. Said compounds are useful as FGFR inhibitors. The invention also relates to

DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS

The invention relates to compounds of Formula (I), wherein the substituens are as defined in the specification, in free form or in the form of a pharmaceutically acceptable salt, solvate, ester, N-oxide thereof; processes for the preparation thereof; to p